H19 and breast neoplasm: In addition, our team recently highlighted a stem cell gene signature (Aldh1a1+; CD44+/CD24−) in breast tumors expressing higher H19. Moreover, these gene signatures were also associated with enhanced H19-derived miR-675 expression, suggesting a role for both H19 and miR-675 in the enrichment of breast CSCs [53].